A Adaptive Design Clinical Trial to Evaluate the Efficacy and Safety of TDI01 Suspension in the Treatment of Idiopathic Pulmonary Fibrosis (IPF)

Clinical trial NCT07464912 · RECRUITING

Trial details

NCT number: NCT07464912
Sponsor: Beijing Tide Pharmaceutical Co., Ltd
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Idiopathic Pulmonary Fibrosis (IPF)

Start date: 2025-12-24
Primary completion: 2029-07-30
Enrollment: 508

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.